{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:17Z","timestamp":1791176837428,"version":"4.1.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:p>There is increasing evidence for rapid nongenomic effects of aldosterone. Aldosterone has been demonstrated to alter intracellular pH and calcium in isolated cells. However, few studies have correlated these effects with aldosterone-mediated physiological responses. Therefore, we studied rapid effects of aldosterone on vascular reactivity, intracellular Ca2+, and pH in resistance vessels. Furthermore, we explored whether the new antimineralocorticoid drug eplerenone could effectively block nongenomic aldosterone-mediated effects. The vasoconstrictor action of aldosterone was examined directly by determining the diameter of small resistance mesenteric vessels (160\u2013200 \u03bcm resting diameter), simultaneously with intracellular pH or Ca2+. Aldosterone (10 nm) caused a rapid constriction of resistance vessels (8.1% \u00b1 1.0% reduction in the diameter below control conditions, P &amp;lt; 0.05). Aldosterone potentiated phenylephrine-mediated constriction in small and large mesenteric vessels. Aldosterone induced a rapid increase of intracellular Ca2+ and cellular alkalinization. Vasoconstrictor action of aldosterone and nongenomic effects on the sodium-proton exchanger (NHE1) activity or intracellular Ca2+ responses was abolished by eplerenone. The vasoconstrictor response of aldosterone was related to phosphatidylinositol 3-kinase (PI3-K): the hormone decreased protein kinase B phosphorylation; pharmacological inhibition of PI3-K (10 \u03bcm LY294002 or 1 \u03bcm wortmannin) increased arterial contractility. Inhibitors of ERK 1\/2 phosphorylation (15 \u03bcm PD98059) had no effect on aldosterone-mediated vasoconstriction. Inhibition of protein kinase C with 1 \u03bcm bi-sindolylmaleimide I and\/or inhibition of NHE1 with 100 \u03bcm amiloride abolished aldosterone vasoconstrictor action of resistance mesenteric arteries. We conclude that aldosterone-mediated increase in vascular tone is related to a nongenomic mechanism that involves protein kinase C, PI3-K, and NHE1 activity. Eplerenone is an effective blocker of nongenomic effects of aldosterone in vascular tissue.<\/jats:p>","DOI":"10.1210\/en.2004-1130","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T01:24:04Z","timestamp":1100827444000},"page":"973-980","source":"Crossref","is-referenced-by-count":121,"title":["Eplerenone Blocks Nongenomic Effects of Aldosterone on the Na+\/H+ Exchanger, Intracellular Ca2+ Levels, and Vasoconstriction in Mesenteric Resistance Vessels"],"prefix":"10.1210","volume":"146","author":[{"given":"Luis","family":"Michea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Delpiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Hitschfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Lobos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lavandero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa T.","family":"Marusic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613121739100_R1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb04415.x","article-title":"The pathophysiology of aldosterone in the cardiovascular system.","volume":"970","author":"Rocha","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"2020071613121739100_R2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med."},{"key":"2020071613121739100_R3","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1067\/mhj.2002.129971","article-title":"New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone","volume":"144","author":"Funder","year":"2002","journal-title":"Am Heart J"},{"key":"2020071613121739100_R4","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"2020071613121739100_R5","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/en.2003-0039","article-title":"Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis.","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"2020071613121739100_R6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues.","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2020071613121739100_R7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3317\/jraas.2003.024","article-title":"Toward a broader understanding of aldosterone in congestive heart failure.","volume":"4","author":"Weber","year":"2003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2020071613121739100_R8","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/endo.142.8.8339","article-title":"Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.","volume":"142","author":"Fujisawa","year":"2001","journal-title":"Endocrinology"},{"key":"2020071613121739100_R9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","article-title":"Role of 11\u03b2-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries.","volume":"35","author":"Alzamora","year":"2000","journal-title":"Hypertension"},{"key":"2020071613121739100_R10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.25.1.117","article-title":"Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells.","volume":"25","author":"Christ","year":"1995","journal-title":"Hypertension"},{"key":"2020071613121739100_R11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0008-6363(96)88565-8","article-title":"Aldosterone specific membrane receptors, rapid activation of the sodium-hydrogen exchanger, and cardiovascular implications.","volume":"29","author":"Wehling","year":"1995","journal-title":"Cardiovasc Res"},{"key":"2020071613121739100_R12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1006\/cbir.1997.0220","article-title":"Rapid aldosterone-induced cell volume increase of endothelial cells measured by the atomic force microscope.","volume":"21","author":"Schneider","year":"1997","journal-title":"Cell Biol Int"},{"key":"2020071613121739100_R13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1210\/en.2002-220950","article-title":"Nongenomic effect of aldosterone on Na+, K+-adenosine triphosphatase in arterial vessels.","volume":"144","author":"Alzamora","year":"2003","journal-title":"Endocrinology"},{"key":"2020071613121739100_R14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1152\/physrev.00003.2003","article-title":"Nongenomic steroid action: controversies, questions, and answers.","volume":"83","author":"Losel","year":"2003","journal-title":"Physiol Rev"},{"key":"2020071613121739100_R15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/01.ASN.0000083982.74108.54","article-title":"Nongenomic vascular action of aldosterone in the glomerular microcirculation.","volume":"14","author":"Arima","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2020071613121739100_R16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.RES.0000106135.02935.E1","article-title":"Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone.","volume":"93","author":"Uhrenholt","year":"2003","journal-title":"Circ Res"},{"key":"2020071613121739100_R17","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.0000093188.53554.44","article-title":"Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation.","volume":"108","author":"Liu","year":"2003","journal-title":"Circulation"},{"key":"2020071613121739100_R18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/en.2003-1137","article-title":"Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C.","volume":"145","author":"Mihailidou","year":"2004","journal-title":"Endocrinology"},{"key":"2020071613121739100_R19","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"2020071613121739100_R20","doi-asserted-by":"crossref","first-page":"H1793","DOI":"10.1152\/ajpheart.00990.2003","article-title":"Estradiol-induced expression of N(+)-K(+)-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors","volume":"286","author":"Palacios","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613121739100_R21","doi-asserted-by":"crossref","first-page":"H1088","DOI":"10.1152\/ajpheart.2001.280.3.H1088","article-title":"Simultaneous arterial calcium dynamics and diameter measurements: application to myoendothelial communication","volume":"280","author":"Schuster","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613121739100_R22","first-page":"279","article-title":"Blaustein MP2000 Ouabain augments Ca(2+) transients in arterial smooth muscle without raising cytosolic Na(+).","author":"Arnon","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613121739100_R23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00498250310001649341","article-title":"Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data.","volume":"34","author":"Cook","year":"2004","journal-title":"Xenobiotica"},{"key":"2020071613121739100_R24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2003.10.044","article-title":"Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.","volume":"217","author":"Baxter","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613121739100_R25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2003.10.008","article-title":"The 45-year story of the development of an anti-aldosterone more specific than spironolactone.","volume":"217","author":"Menard","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613121739100_R26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone: a selective aldosterone receptor antagonist (SARA).","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"2020071613121739100_R27","first-page":"3528","article-title":"Short term cardiovascular effects of aldosterone in healthy male volunteers.","volume":"84","author":"Schmidt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613121739100_R28","first-page":"3517","article-title":"Rapid cardiovascular action of aldosterone in man.","volume":"83","author":"Wehling","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613121739100_R29","doi-asserted-by":"crossref","first-page":"H2282","DOI":"10.1152\/ajpheart.00544.2002","article-title":"Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists","volume":"283","author":"Massett","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613121739100_R30","first-page":"H1178","article-title":"Increased Ca2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries","volume":"277","author":"Gokina","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071613121739100_R31","first-page":"H1586","article-title":"Evidence for protein kinase C involvement in arteriolar myogenic reactivity","volume":"259","author":"Hill","year":"1990","journal-title":"Am J Physiol"},{"key":"2020071613121739100_R32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1152\/jappl.2001.91.2.973","article-title":"Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity.","volume":"91","author":"Hill","year":"2001","journal-title":"J Appl Physiol"},{"key":"2020071613121739100_R33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0008-6363(99)00106-6","article-title":"Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C.","volume":"43","author":"Ungvari","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2020071613121739100_R34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","article-title":"Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats.","volume":"43","author":"Nishiyama","year":"2004","journal-title":"Hypertension"},{"key":"2020071613121739100_R35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1998.tb10187.x","article-title":"Activation of the mitogen-activated protein kinase pathway via the 5-HT2A receptor.","volume":"861","author":"Watts","year":"1998","journal-title":"Ann NY Acad Sci"},{"key":"2020071613121739100_R36","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0895-7061(98)00127-7","article-title":"Activation of Na+, H+ exchanger produces vasoconstriction of renal resistance vessels.","volume":"11","author":"Tepel","year":"1998","journal-title":"Am J Hypertens"},{"key":"2020071613121739100_R37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/physrev.1997.77.1.51","article-title":"Molecular physiology of vertebrate Na+\/H+ exchangers.","volume":"77","author":"Wakabayashi","year":"1997","journal-title":"Physiol Rev"},{"key":"2020071613121739100_R38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.2154036","article-title":"Growth factors induce phosphorylation of the Na+\/H+ antiporter, a glycoprotein of 110 kDa.","volume":"247","author":"Sardet","year":"1990","journal-title":"Science"},{"key":"2020071613121739100_R39","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1016\/S0021-9258(17)36887-4","article-title":"The Na+\/H+ exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites.","volume":"269","author":"Bertrand","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071613121739100_R40","doi-asserted-by":"crossref","first-page":"12631","DOI":"10.1073\/pnas.93.22.12631","article-title":"A calcineurin homologous protein inhibits GTPase-stimulated Na+\/H+ exchange.","volume":"93","author":"Lin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613121739100_R41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1074\/jbc.272.1.271","article-title":"The p42\/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+\/H+ exchanger (NHE1 isoform) in response to growth factors.","volume":"272","author":"Bianchini","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071613121739100_R42","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/01.HYP.29.6.1265","article-title":"A 90-kD Na(+)-H+ exchanger kinase has increased activity in spontaneously hypertensive rat vascular smooth muscle cells.","volume":"29","author":"Phan","year":"1997","journal-title":"Hypertension"},{"key":"2020071613121739100_R43","first-page":"104","article-title":"\u03b1-Adrenoceptors in vascular smooth muscle: all is not well.","volume":"28","author":"Daniel","year":"1991","journal-title":"Blood Vessels"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/3\/973\/9022078\/endo0973.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/3\/973\/9022078\/endo0973.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T02:37:43Z","timestamp":1624934263000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/146\/3\/973\/2499856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2004-1130","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}